rs145005596
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001291867.2(NHS):c.3374C>T(p.Ser1125Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000515 in 1,209,121 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 190 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 10/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001291867.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NHS | NM_001291867.2 | c.3374C>T | p.Ser1125Leu | missense_variant | 7/9 | ENST00000676302.1 | NP_001278796.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NHS | ENST00000676302.1 | c.3374C>T | p.Ser1125Leu | missense_variant | 7/9 | NM_001291867.2 | ENSP00000502262 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000501 AC: 56AN: 111731Hom.: 0 Cov.: 23 AF XY: 0.000236 AC XY: 8AN XY: 33919
GnomAD3 exomes AF: 0.000316 AC: 58AN: 183271Hom.: 0 AF XY: 0.000340 AC XY: 23AN XY: 67743
GnomAD4 exome AF: 0.000517 AC: 567AN: 1097336Hom.: 0 Cov.: 32 AF XY: 0.000502 AC XY: 182AN XY: 362702
GnomAD4 genome AF: 0.000501 AC: 56AN: 111785Hom.: 0 Cov.: 23 AF XY: 0.000235 AC XY: 8AN XY: 33983
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 13, 2015 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | May 28, 2015 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2017 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Nance-Horan syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 23, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at